MassDevice

Medtronic wins FDA clearance for Nellcor pulse oximetry system with intelligent processor

Medtronic (NYSE:MDT) has received FDA 510(k) clearance for its Nellcor pulse oximetry system with the Nell-EQ intelligent ...
CSR Wire

Medtronic Study of Investigational Nellcor™ Pulse Oximetry Technology Demonstrates Positive Results Across a Full Range of Skin Tones

January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...
Finanznachrichten

Medtronic Receives FDA Clearance for Nellcor Pulse Oximetry System With Nell-EQ Intelligent Processor, a New Technology Designed To Improve Reliability Across Diverse Patients ...

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor pulse oximetry system with Nell-EQ intelligent processor.
CSR Wire

Medtronic Receives FDA Clearance for Nellcor™ Pulse Oximetry System With Nell-EQ™ Intelligent Processor, a New Technology Designed To Improve Reliability Across Diverse ...

June 8, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced FDA 510(k) clearance of its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor. The Nell-EQ™ ...